2. 尊龙凯时

      Development Progress
      Development Progress
      R&D Projects Registration Category Indication/Therapeutic Use Phase I Phase II Phase III Approved
      PUDK-HGF Biological Products Category 1 Rest pain and/or ischemic ulcers in limbs due to severe ischemic disease of the lower extremities
      Remazolam Besylate for Injection New Indication Chemical category 1 Sedation during intensive care unit (ICU)
      PARP Inhibitors Chemical category 1 Ovarian cancer, breast cancer, lung cancer, etc
      BTK Inhibitors Chemical category 1 Chronic spontaneous urticaria
      HW021199 Tablets Chemical category 1 Treatment of idiopathic pulmonary fibrosis
      RFUS-144 Injection Chemical category 1 Treatment of pain and pruritus
      Bai-re-si Pills Chemical category 1 Treatment of stable vitiligo
      Compound Yixie Granules Chemical category 1 Hyperuricemia in the non-acute phase of gout and syndrome of stasis of dampness and turbidness
      LL-50 Injection Chemical category 1 Control of surgical anesthesia and acute pain
      HW060015 Capsules Chemical category 1 Patients with advanced solid tumors
      HW091077 Tablets Chemical category 1 Patients with refractory chronic cough
      YJJS-71 Chemical category 1 New skeletal muscle relaxation drug
      RF16001 for Injection Chemical category 2 Postoperative analgesia
      Sufentanil Transdermal Patch Chemical category 2 Treatment of moderate to severe chronic pain
      Oxycodone and Acetaminophen Extended-release Tablets Chemical category 2 Analgesia of moderate to severe neuralgia
      Tapentadol Hydrochloride Preparations Chemical category 3 Relief of moderate to severe pain in adults of 18 years of age and older; treatment of pain that requires long-term treatment with opioid analgesics
      Fentanyl Citrate Oral Patch Chemical category 3 For the treatment of explosive pain in patients with cancerous pain who have been using opioids continuously
      Methylnaltrexone Bromide Preparations Chemical category 3 For the treatment of opioid-induced constipation (OIC) in adults with chronic non-cancerous pain